Categories: Technology

BionIT Labs Launches Adams Hand for Humanoids and Service Robots

Image by BionIT Labs

SOLETO, Italy, Jan. 19, 2026 (GLOBE NEWSWIRE) — BionIT Labs, a pioneer in human-machine interfaces, today announced that Adam’s Hand for Physical AI systems is now available for integration with robotics platforms, closing a long-standing gap between artificial intelligence and the physical world. The announcement follows a debut at CES 2026, where Adam’s Hand demonstrated advanced dexterity on two humanoid robots.

While BionIT Labs’ roots are in advanced prosthetics, the company has evolved Adam’s Hand from assistive medical devices to AI-native robotic dexterity infrastructure. The platform delivers what Physical AI has been missing: high-fidelity, real-world manipulation data paired with proven, human-scale hardware.

“AI can reason, plan, and predict, but without dexterity, it cannot act,” said Giovanni Zappatore, Founder and CEO of BionIT Labs. “Dexterity is the missing link. Without embodied intelligence, Physical AI cannot scale. Adam’s Hand is designed from the ground up to bring AI into contact with the real world.”

BionIT Labs supports robotics manufacturers, research groups, and system integrators as an integration partner, focusing on applied testing and performance validation in real operating conditions.

At CES 2026, Adam’s Hand was showcased on:

  • Robee R, an industrial humanoid developed with STMicroelectronics, demonstrating robust functional grip and operational reliability in real-world scenarios.
  • Robee M, a medical humanoid featured at the Intel booth, demonstrating safe and natural human-robot interaction.

Watch Adam’s Hand in action as it interacts naturally with the world: https://www.youtube.com/shorts/kM4Zt-3iba8  

“Prosthetics and robotics share the same non-negotiable constraints,” added Zappatore. “You need dexterity you can rely on, sensing that remains stable over time, maintenance aligned with real-world operation, and hardware engineered for continuous use. Embodied intelligence exposes these constraints immediately, and our technology has been built where failure is not an option.”

All robotics work at BionIT Labs follows the same safety, ethics, and compliance standards established in medical-device development, including human-centered design and responsible handling of human-related data.

Adam’s Hand for Physical AI systems is available now for robotics integration projects, including proof-of-concept deployments and collaborative development programs.

For more information, visit https://bionitlabs.com/robotics/

About BionIT Labs

BionIT Labs already established in the prosthetic field, develops advanced human-machine interfaces and robotics solutions. Its flagship product, Adam’s Hand, brings real-world dexterity to humanoid and service robots.

Media Contact:
Cristina Longo
Marketing & Communication Manager
+39 3933800324
c.longo@bionitlabs.com
https://bionitlabs.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1f0dec5f-31dc-4892-a273-8b9203d8cb2e

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2428bfa4-cc98-471e-b5f2-a06c693a3a14

GlobeNews Wire

Recent Posts

MAGFAST Moves Christmas to July and Adds a Full Spectrum of Color to the Worlds Only Complete Charging System

HUNTINGTON BEACH, Calif., July 03, 2026 (GLOBE NEWSWIRE) -- MAGFAST, creator of a unique, integrated…

4 hours ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase

ANNECY, France, July 03, 2026 (GLOBE NEWSWIRE) -- XPPen, a global leading brand in digital…

4 hours ago

Beyond Pet-Friendly: PureCozy Introduces a New Vision for Human-Pet Living

Denver, CO, July 03, 2026 (GLOBE NEWSWIRE) -- From DualSeason Rug™ to Furniture-Integrated Pet Spaces,…

4 hours ago

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program

HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink:…

4 hours ago

Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations

MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”…

4 hours ago

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

July 03, 2026 16:30 ET  | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026…

4 hours ago